Olivier Danos

Company: REGENXBIO
Job title: Chief Scientific Officer
Seminars:
Q&A Panel Discussion: Delivery 11:50 am
• Comparing different patient populations for different indications and their suitability for different delivery routes • Discussing biodistribution vs invasive procedures for delivery to the brain • Exploring the risk/benefit of different routes of administration, is the data translatable? • Introducing technology advances for the delivery devices, where is there room for improvement?Read more
day: Day Two
Safety & Efficacy of Intra-Cisternal Administration of AAV Vectors 10:50 am
• Evaluating the intra-cisternal route: pros and cons • Exploring preclinical studies of toxicity and biodistribution • Discussing clinical validationRead more
day: Day Two